Clonetics Diabetic Type I and Type II human skeletal muscle myoblasts

Friday, 22 July, 2011 | Supplied by: Lonza Australia Pty Ltd



Clonetics Diabetic Type I and Type II human skeletal muscle myoblasts (HSMM) are isolated from donors diagnosed with either Diabetes Type I or Diabetes Type II. Additional donor information is available by contacting Lonza’s Scientific Support.

Diseased cells are tested in the same SkGM-2 Skeletal Muscle Growth Media as the normal cells, allowing for easy comparisons between diseased and normal tissue.

Both diseased and normal HSMM cultures can be used for the study of cellular development and differentiation, insulin uptake or resistance, tissue repair and the metabolic effects of diabetes on skeletal muscle tissue. The myoblasts are claimed to be convenient and easy to use, allowing users to focus on results.

Cryopreserved HSMM are supplied as frozen primary-derived cells.

Clonetics cells, medium and reagents are quality tested together and are guaranteed to give optimum performance.

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

Merck VirusExpress Lentiviral Production Platform

The platform helps to overcome lentiviral production challenges and can reduce process...

Diaclone research tools for cytokine storm monitoring

Diaclone provides a large panel of research tools, monoclonal antibodies and ELISA kits for...

BioLamina Biosilk biomaterial for 3D cell culture of hPSCs

BioLamina's Biosilk is a 3D cell culture biomaterial made from recombinant spider silk...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd